Cargando…

Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients

BACKGROUND: Multiple sclerosis (MS) is an autoimmune disorder characterized by chronic inflammation, demyelination, and neuronal damage. During autoimmunity, cytokines are important mediators of the inflammation. In this line, interleukin-27 (IL-27) modulates inflammation and can be produced directl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lalive, Patrice H., Kreutzfeldt, Mario, Devergne, Odile, Metz, Imke, Bruck, Wolfgang, Merkler, Doron, Pot, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525372/ https://www.ncbi.nlm.nih.gov/pubmed/28738904 http://dx.doi.org/10.1186/s12974-017-0919-1

Ejemplares similares

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
por: Weber, Martin S., et al.
Publicado: (2018)

Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis
por: Traub, Jan, et al.
Publicado: (2019)

Cerebrospinal Fluid Interleukin-6 in Central Nervous System Inflammatory Diseases
por: Wullschleger, Alexandre, et al.
Publicado: (2013)

Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination
por: Rodriguez, Enrique Garea, et al.
Publicado: (2014)

Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
por: Metz, Imke, et al.
Publicado: (2016)

Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model
por: Romanelli, Elisa, et al.
Publicado: (2016)

Interleukin-6, a Major Cytokine in the Central Nervous System
por: Erta, María, et al.
Publicado: (2012)

Rescue therapy with alemtuzumab in B cell/antibody-mediated multiple sclerosis
por: Akgün, Katja, et al.
Publicado: (2018)

Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions
por: Planas, Raquel, et al.
Publicado: (2015)

The IL‐27/IL‐27R axis is altered in CD4(+) and CD8(+) T lymphocytes from multiple sclerosis patients
por: Clénet, Marie‐Laure, et al.
Publicado: (2021)

Remodeling of Axonal Connections Contributes to Recovery in an Animal Model of Multiple Sclerosis
por: Kerschensteiner, Martin, et al.
Publicado: (2004)

Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
por: Singh, Shailender, et al.
Publicado: (2013)

CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study
por: Häusler, Darius, et al.
Publicado: (2021)

Exploring the role of interleukin-27 as a regulator of neuronal survival in central nervous system diseases
por: Nortey, Andrea N., et al.
Publicado: (2022)

IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis
por: Benkhoucha, Mahdia, et al.
Publicado: (2012)

Cell type-specific Nrf2 expression in multiple sclerosis lesions
por: Licht-Mayer, Simon, et al.
Publicado: (2015)

Cytokines and Myelination in the Central Nervous System
por: Schmitz, Thomas, et al.
Publicado: (2008)

B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation
por: Bjarnadóttir, Kristbjörg, et al.
Publicado: (2016)

The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research
por: Steinemann, Nina, et al.
Publicado: (2018)

CD4(+)c-Met(+)Itgα4(+) T cell subset promotes murine neuroinflammation
por: Benkhoucha, Mahdia, et al.
Publicado: (2022)

Glial Cells Express Nuclear Nrf2 After Fumarate Treatment for Multiple Sclerosis and Psoriasis
por: Metz, Imke, et al.
Publicado: (2015)

Cytokine Landscape in Central Nervous System Metastases
por: Marin, Julie, et al.
Publicado: (2022)

Interleukin-27 as a Novel Biomarker for Early Cardiopulmonary Failure in Enterovirus 71-Infected Children with Central Nervous System Involvement
por: Huang, Mingyuan, et al.
Publicado: (2016)

The role of interleukin-6 in central nervous system demyelination
por: Petković, Filip, et al.
Publicado: (2016)

Therapeutic Opportunities of Interleukin-33 in the Central Nervous System
por: Sun, Yun, et al.
Publicado: (2021)

Immunological Mechanism of Action and Clinical Profile of Disease-Modifying Treatments in Multiple Sclerosis
por: Du Pasquier, Renaud A., et al.
Publicado: (2014)

Expression of IL-27 by Tumor Cells in InvasCutaneous and Metastatic Melanomas
por: Gonin, Julie, et al.
Publicado: (2013)

Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis
por: Thomas, Katja, et al.
Publicado: (2014)

Correction: Expression of IL-27 by Tumor Cells in Invasive Cutaneous and Metastatic Melanomas
por: Gonin, Julie, et al.
Publicado: (2013)

Antibody signatures in patients with histopathologically defined multiple sclerosis patterns
por: Stork, Lidia, et al.
Publicado: (2020)

Repetitive Pertussis Toxin Promotes Development of Regulatory T Cells and Prevents Central Nervous System Autoimmune Disease
por: Weber, Martin S., et al.
Publicado: (2010)

Regulation of Defense Responses against Protozoan Infection by Interleukin-27 and Related Cytokines
por: Yoshida, Hiroki, et al.
Publicado: (2007)

Ligand-Mediated Targeting of Cytokine Interleukin-27 Enhances Its Bioactivity In Vivo
por: Figueiredo, Marxa L., et al.
Publicado: (2020)

T Cell-Dependence of Lassa Fever Pathogenesis
por: Flatz, Lukas, et al.
Publicado: (2010)

Interleukin 1 of the central nervous system is produced by ameboid microglia
Publicado: (1986)

CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis
por: Khaiboullina, Svetlana F., et al.
Publicado: (2015)

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
por: Spadaro, Melania, et al.
Publicado: (2016)

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy
por: Metz, Imke, et al.
Publicado: (2011)

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
por: Metz, Imke, et al.
Publicado: (2016)

Multiple Sclerosis and the Blood-Central Nervous System Barrier
por: Palmer, Alan M.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_346drg7iaohgkgbkufenq8h537